Company research
Krystal Biotech, Inc.
CIK 1711279Updated Sep 24, 2026
SecurityKRYS · NASDAQ · equity
KRYS price & chart
Loading TradingView…
NASDAQ:KRYS on TradingView ↗In the news
Krystal Biotech (NASDAQ:KRYS) director Dino Rossi sells $8.2m shares ↗
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026 ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,333,794,000Source | 1,055,838,000Source | 818,355,000Source | 558,450,000Source |
| Property, Plant and Equipment, NetUSD | 150,776,000Source | 155,168,000Source | 161,202,000Source | 161,684,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 496,304,000Source | 344,865,000Source | 358,328,000Source | 161,900,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 127,425,000Source | 104,746,000Source | 42,040,000Source | 0Source |
| Inventory, NetUSD | 40,475,000Source | 26,508,000Source | 6,985,000Source | 0Source |
| Assets, CurrentUSD | 1,024,602,000Source | 742,045,000Source | 587,909,000Source | 383,779,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 14,905,000Source | 13,274,000Source | 6,706,000Source | 4,608,000Source |
| Operating Lease, Right-of-Use AssetUSD | 7,239,000Source | 6,280,000Source | 7,027,000Source | 8,042,000Source |
| Other Assets, NoncurrentUSD | 287,000Source | 231,000Source | 263,000Source | 324,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 114,234,000Source | 109,458,000Source | 39,714,000Source | 36,219,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 1,194,261,000Source | 1,127,238,000Source | 1,047,830,000Source | 803,718,000Source |
| Retained Earnings (Accumulated Deficit)USD | 24,163,000Source | -180,668,000Source | -269,827,000Source | -280,759,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 1,136,000Source | -190,000Source | 638,000Source | -728,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,219,560,000Source | 946,380,000Source | 778,641,000Source | 522,231,000Source |
| Liabilities and EquityUSD | 1,333,794,000Source | 1,055,838,000Source | 818,355,000Source | 558,450,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 102,942,000Source | 101,995,000Source | 33,094,000Source | 28,847,000Source |
| Operating Lease, Liability, CurrentUSD | 1,771,000Source | 1,217,000Source | 1,474,000Source | 1,561,000Source |
| Accounts Payable, CurrentUSD | 3,238,000Source | 4,985,000Source | 4,132,000Source | 3,981,000Source |
| Operating Lease, Liability, NoncurrentUSD | 7,568,000Source | 6,044,000Source | 6,620,000Source | 7,372,000Source |
| Other Liabilities, NoncurrentUSD | 3,724,000Source | 1,419,000Source | — | — |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 827,800,000Source | 597,500,000Source | 532,200,000Source | — |
| Deferred Tax Liabilities, NetUSD | 15,480,000Source | 15,044,000Source | 14,602,000Source | 3,303,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 54,514,000Source | 49,127,000Source | 39,933,000Source | 33,230,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 22,124,000Source | 62,706,000Source | 42,040,000Source | 0Source |
| Increase (Decrease) in InventoriesUSD | 6,286,000Source | 11,907,000Source | 4,475,000Source | 0Source |
| Increase (Decrease) in Accounts PayableUSD | 826,000Source | 1,011,000Source | -101,000Source | -1,254,000Source |
| Deferred Income Tax Expense (Benefit)USD | -27,275,000Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 200,865,000Source | 123,420,000Source | -88,804,000Source | -100,569,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -58,417,000Source | -163,439,000Source | 82,638,000Source | -114,083,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 11,951,000Source | 4,238,000Source | 11,799,000Source | 52,979,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | 749,000Source | 649,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 8,705,000Source | 27,014,000Source | 202,750,000Source | 35,347,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 151,439,000Source | -13,463,000Source | 196,428,000Source | -179,346,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 496,304,000Source | 344,865,000Source | 358,328,000Source | 161,900,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 14,793,000Source | 5,665,000Source | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 286,000Source | -458,000Source | -156,000Source | -41,000Source |
| Additional Financial Items | ||||
| AmortizationUSD | — | — | -1,278,000Source | 1,412,000Source |
| Share-based Payment Arrangement, ExpenseUSD | 54,514,000Source | — | — | — |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 827,800,000Source | 597,500,000Source | 532,200,000Source | — |
| DepreciationUSD | 5,724,000Source | 5,967,000Source | 5,007,000Source | 2,643,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -1,200,000Source | — | — | — |
| Gain (Loss) on Disposition of Intangible AssetsUSD | 0Source | 0Source | 100,000,000Source | 0Source |
| Gain (Loss) Related to Litigation SettlementUSD | 0Source | — | — | — |
| Gain (Loss) on Disposition of Assets for Financial Service OperationsUSD | — | — | -27,000Source | -72,000Source |
| General and Administrative ExpenseUSD | — | — | 98,401,000Source | 77,735,000Source |
| Income Tax Expense (Benefit)USD | -15,360,000Source | 6,197,000Source | 1,965,000Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | 204,831,000Source | 89,159,000Source | 10,932,000Source | -139,975,000Source |
| Operating ExpensesUSD | 227,835,000Source | 224,820,000Source | 160,426,000Source | 145,196,000Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 0Source | 203,499,000Source | 35,996,000Source |
| Proceeds from Stock Options ExercisedUSD | 22,661,000Source | 32,400,000Source | — | — |
| Realized Investment Gains (Losses)USD | 5,953,000Source | 6,069,000Source | 5,092,000Source | 570,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 389,130,000Source | 290,515,000Source | 50,699,000Source | 0Source |
| Selling, General and Administrative ExpenseUSD | 146,741,000Source | 113,686,000Source | — | — |
| Operating Income (Loss)USD | 161,295,000Source | 65,695,000Source | -109,727,000Source | -145,196,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 189,471,000Source | 95,356,000Source | 12,897,000Source | -139,975,000Source |
| Income Tax Expense (Benefit)USD | -15,360,000Source | 6,197,000Source | 1,965,000Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | 204,831,000Source | 89,159,000Source | 10,932,000Source | -139,975,000Source |
| Earnings Per Share, BasicUSD per share | 7.08Source | 3.12Source | 0.4Source | -5.49Source |
| Earnings Per Share, DilutedUSD per share | 6.84Source | 3Source | 0.39Source | -5.49Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 28,944,000Source | 28,592,000Source | 27,154,190Source | 25,491,721Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 29,951,000Source | 29,740,000Source | 27,751,809Source | 25,491,721Source |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 11,915,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -1,200,000Source | — | — | — |
| Gain (Loss) Related to Litigation SettlementUSD | 0Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 98,401,000Source | 77,735,000Source |
| Interest ExpenseUSD | — | — | 0Source | 0Source |
| Interest Income (Expense), Nonoperating, NetUSD | 28,176,000Source | 29,661,000Source | — | — |
| Operating ExpensesUSD | 227,835,000Source | 224,820,000Source | 160,426,000Source | 145,196,000Source |
| Realized Investment Gains (Losses)USD | 5,953,000Source | 6,069,000Source | 5,092,000Source | 570,000Source |
| Research and Development ExpenseUSD | 58,045,000Source | 53,573,000Source | 46,431,000Source | 42,461,000Source |